Study of aspirin effects on Permcath function in dialysis patients

Study of effects use and without use of aspirin on Permcath function in dialysis patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2013100114333N8

Enrollment

236

Registered

2013-10-14

Start date

2013-03-21

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Advanced renal failure. End stage renal disease

Interventions

Intervention 1: The intervention group received 80 mg aspirin a day after placing Permcath daily for 6 months. Intervention 2: The control group didn’t get any drug. Not applicable.

Treatment - Drugs

The intervention group received 80 mg aspirin a day after placing Permcath daily for 6 months

The control group didn’t get any drug. Not applicable

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Patients who are allowed to receive aspirin, matched for age, sex, diabetes, cardiovascular disease and written informed consent. Exclusion criteria: Patients who have coagulation disorders or use anticoagulant drugs, patients who are suffering from cancer or gastrointestinal bleeding

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Infection. Timepoint: Once a month for 6 months. Method of measurement: Based on physical examination, blood culture and discharge from permcath location.;Bleeding from Permcath location. Timepoint: Once a month for 6 months. Method of measurement: History and physical examination based on the initial amount of bleeding which doesn’t stop with primary cares and needs to surgical intervention.;Gastrointestinal bleeding. Timepoint: Once a month for 6 months. Method of measurement: blood in the stool or clinical signs such as bloody vomiting and abdominal pain.;Lifetime of Permcath. Timepoint: Once a month for 6 months. Method of measurement: Observing the patient’s record.	—

Measure

Time frame

Infection. Timepoint: Once a month for 6 months. Method of measurement: Based on physical examination, blood culture and discharge from permcath location.;Bleeding from Permcath location. Timepoint: Once a month for 6 months. Method of measurement: History and physical examination based on the initial amount of bleeding which doesn’t stop with primary cares and needs to surgical intervention.;Gastrointestinal bleeding. Timepoint: Once a month for 6 months. Method of measurement: blood in the stool or clinical signs such as bloody vomiting and abdominal pain.;Lifetime of Permcath. Timepoint: Once a month for 6 months. Method of measurement: Observing the patient’s record.

—

Countries

Iran (Islamic Republic of)

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026